<DOC>
	<DOCNO>NCT00868010</DOCNO>
	<brief_summary>This 12-week , randomize , placebo control study determine donepezil ( Aricept ) treatment rehabilitation stroke improves functional recovery .</brief_summary>
	<brief_title>Enhancing Rehabilitation After Stroke</brief_title>
	<detailed_description>Stroke lead cause disability US ( Thom 2006 ) . The total number stroke survivor ( currently estimate 5.5 million Americans ) continue increase population age medical management acute stroke continue improve . Given stroke 's devastating impact activity daily live large number Americans afflict , improve acute medical rehabilitation outcome stroke great public health importance . Predictors poor functional recovery post-stroke include impairment cognition motivation . Recent evidence indicate acetylcholinesterase inhibitor may improve cognition motivation ; hence , use post-stroke may lead improved rehabilitation outcome . Our group demonstrate use acetylcholinesterase inhibitor donepezil associate improved functional recovery pilot sample ( n = 40 ) elderly , cognitively impaired stroke survivor undergo inpatient rehabilitation . Specifically , 12 week open-label study , subject receive donepezil experience clinically meaningful 14 point great improvement Functional Independence Measure ( FIM ) archival comparator group . Based promising pilot study result , propose 12-week randomize , double-blind , placebo-controlled trial ( follow 12 week off-drug observation period ) order test efficacy donepezil promote post-stroke functional recovery older , cognitively impaired stroke survivor undergo inpatient rehabilitation . We also use randomize controlled trial examine drug 's effect cognition post-stroke ; specifically , drug 's effect cognitive domain ( attention/working memory , information psychomotor speed , episodic memory ) relevant functional outcome .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>1. male female ; 2. age 18 old ; 3. new ischemic stroke within precede 30 day ; 4. admit inpatient facility UPMC Institute Rehabilitation Research poststroke rehabilitation . 1. primary hemorrhagic stroke ; 2. current use cholinomimetic drug include tacrine , donepezil , galantamine , rivastigmine ; 3. contraindication AchEi therapy include bradycardia ( &lt; 50 bpm ) , severe asthma COPD require nebulized medication , active upper GI bleed untreated gastric ulcer ; 4. myocardial infarction , poorly control congestive heart failure , coronary bypass surgery within last 3 month ; 5. current require use anticholinergic medication ( e.g. , bladder spasm ) ; 6. current aphasia severe enough prevent valid neuropsychiatric assessment ( e.g. , score &lt; 9 Token Test , part I score &lt; 14 ( &lt; 80 % accuracy ) repetition task Boston Diagnostic Aphasia Examination ) ; 7. current Major Depressive Episode AND HRSD &gt; 20 ; 8. current active suicidal ideation , plan , intent ; 9. current mania hypomania ; 10. current psychosis ; 11. meeting DMSIV TR alcohol substance abuse dependence criterion within precede 3 month ; 12. subject and/or family informant speak English ; 13. history progressive unstable CNS disease ( e.g. , multiple sclerosis , Parkinson 's disease , HIV CNS involvement ) ; 14. medically unstable ( determined review subject 's medical status treating ( clinical ) physician review standard blood test ) ; 15. history sensitivity donepezil ; 16. potential subject without pacemaker implantable defibrillator , exclusion criterion include ( ) ECG evidence second third degree heart block ( b ) ECG evidence trifascicular block ( LBBB 1st degree AV Block ; RBBB , leave anterior left posterior hemiblock , 1st degree AV block ) ( c ) history syncope within 1 year RBBB LBBB . 17 . For female childbearing age , current pregnancy , plan become pregnant study drug , refusal avoid pregnancy study drug . 18 . For female childbearing age , current breast feeding . 19. suicidal attempt past one year , 20. inpatient admission depression past one year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>stroke</keyword>
	<keyword>donepezil</keyword>
	<keyword>recovery</keyword>
</DOC>